GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Construction In Progress

Y-Biologics (XKRX:338840) Construction In Progress : ₩328 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Construction In Progress?

Y-Biologics's quarterly construction in progress declined from Sep. 2024 (₩319 Mil) to Dec. 2024 (₩317 Mil) but then increased from Dec. 2024 (₩317 Mil) to Mar. 2025 (₩328 Mil).

Y-Biologics's annual construction in progress increased from Dec. 2022 (₩301 Mil) to Dec. 2023 (₩378 Mil) but then declined from Dec. 2023 (₩378 Mil) to Dec. 2024 (₩317 Mil).

Y-Biologics Construction In Progress Historical Data

The historical data trend for Y-Biologics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Construction In Progress Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial 3,555.86 3,703.00 301.48 377.82 317.23

Y-Biologics Quarterly Data
Dec17 Dec18 Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 413.56 292.41 318.68 317.23 327.90

Y-Biologics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Y-Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Construction In Progress
Comparable Companies
XKRX:214260 XKRX:251120 XKRX:048530 XKRX:311690 XKRX:278650 XKRX:456070 XKRX:084990 XKRX:235980 XKRX:299660 XKRX:376270 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
B715 Daedeok Biz Center, 17 Techno 4-ro, Yuseong-gu, Daejeon, KOR, 34013
Website
https://www.ybiologics.com
Y-Biologics Inc is a company that has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of the development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics Headlines

No Headlines